Treatment of prostate cancer in vitro and in who with 2-5A-anti-telomerase RNA component

Oncogene

Volumn 19, Issue 18, 2000, Pages 2205-2211

  Kondo, Yasuko ^a,b   Koga, Shoji ^a   Komata, Tadashi ^a,b   Kondo, Seiji ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

2 5A; Antisense; Apoptosis; Prostate cancer; Telomerase

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE; RIBONUCLEASE; RIBONUCLEOPROTEIN; RNA; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALIA; MUS MUSCULUS;

EID: 0034720202     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203538     Document Type: Article

References (29)

1. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW and Harley CB. (1995). Exp. Cell Res., 220, 194-220.
2. Bacchetti S and Counter CM. (1995). Int. J. Oncol., 7, 423-432.
3. Bacchetti S. (1996). Cancer Surveys, 28, 197-216.
4. Blackburn EH. (1991). Nature. 350, 569-573.
5. Cirino NM, Li G, Xiao W, Torrence PF and Silverman RH. (1997). Proc. Natl. Acad. Sci. USA, 94, 1937-1942.
6. Clemens MJ and Williams BR. (1978). Cell. 13, 565-572.
7. de Lange T. (1994). Proc. Natl. Acad. Sci. USA, 91, 2882-2885.
8. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR. Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B. (1995). Science, 269, 1236-1241.
9. Glukhov AI, Zimnik OV, Gordeev SA and Severin SE. (1998). Biochem. Biophs. Res. Commun., 248, 368-371.
10. Harley CB, Futcher AB and Greider CW. (1990). Nature. 345, 458-460.
11. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC. (1990). Nature, 346, 866-868.
12. Kanazawa Y, Ohkawa K, Ueda K, Mita E, Takehara T, Sasaki Y, Kasahara A and Hayashi N. (1996). Biochem. Biophs. Res. Commun., 225, 570-576.
13. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW. (1994). Science, 266, 2011-2015.
14. Kim NW. (1997). Eur. J. Cancer, 33, 781-786.
15. Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B and Barnett GH. (1996). Oncogene, 13, 1279-1285.
16. Kondo S, Kondo Y, Li G, Silverman RH and Cowell JK. (1998a). Oncogene, 16, 3323-3330.
17. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK and Barna BP. (1998b). FASEB J., 12, 801-811.
18. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M and Kubota Y. (1997). J. Urol., 157, 1161-1165.
19. Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G, Williams BR, Torrence PF and Silverman RH. (1994). Science, 265, 789-792.
20. Naitoh J, Witte O and Belldegrun A. (1998). Cancer Res., 58, 2895-2900.
21. Norton JC, Piatyszek MA, Wright WE, Shay JW and Corey DR. (1996). Nature Biotechnol., 14, 615-619.
22. Shay JW and Wright WE. (1996). Curr. Opin. Oncol., 8, 66-71.
23. Sikora K and Pandha H. (1997). Br. J. Urol., 79, 64-68.
24. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW and Coffey DS. (1996). Cancer Res., 56, 218-222.
25. Torrence PF, Maitra RK, Lesiak K, Khamnei S, Zhou A and Silverman RH. (1993). Proc. Natl. Acad. Sci. USA, 90, 1300-1304.
26. Wang J and Walsh K. (1996). Science, 273, 359-361.
27. Wingo PA, Tong T and Bolden S. (1995). CA Cancer J. Clin., 45, 8030.
28. Xiao W, Li G, Lesiak K, Dong B, Silverman RH and Torrence PF. (1994). Bioorg. Med. Chem. Letters, 4, 2609-2614.
29. Zhou A, Hassel BA and Silverman RH. (1993). Cell, 72, 753-765.